Lataa...
Are ovarian cancer stem cells the target for innovative immunotherapy?
Cancer stem cells (CSCs), a subpopulation of cancer cells with the ability of self-renewal and differentiation, are believed to be responsible for tumor generation, progression, metastasis, and relapse. Ovarian cancer, the most malignant gynecological cancer, has consistent pathology behavior with C...
Tallennettuna:
| Julkaisussa: | Onco Targets Ther |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5951213/ https://ncbi.nlm.nih.gov/pubmed/29780254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S155458 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|